Last reviewed · How we verify
NCT06595836
Evaluation of the Performance and Acceptability of a Synthetic Polyisoprene Male Condom Compared to a Natural Rubber Latex Condom
NA trial testing Silicone Lubricated Synthetic polyisoprine condom in Condom Use in 300 participants. Currently enrolling.
31 December 2024
Quick facts
| Lead sponsor | Thai Nippon Rubber Industry Public Company Limited |
|---|---|
| Phase | NA |
| Status | Recruiting now |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | crossover |
| Masking | double |
| Primary purpose | prevention |
| Enrollment | 300 |
| Start date | 2 January 2024 |
| Primary completion | 31 December 2024 |
| Estimated completion | 28 February 2025 |
| Sites | 2 locations across United States |
Drugs / interventions tested
- Silicone Lubricated Synthetic polyisoprine condom
- Silicone Lubricated Natural Rubber Latex Condom
Conditions studied
- Condom Use — all drugs for Condom Use →
Sponsor
Thai Nippon Rubber Industry Public Company Limited
Who can join
Adults 18 to 45, any sex, with Condom Use. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study is a masked (investigators, research staff), two-way crossover, randomized to sequence of use study designed to evaluate the acceptability and functional performance (breakage, slippage) of a silicone lubricated polyisoprene condom and a silicone lubricated natural rubber latex condom.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06595836
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06595836 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Thai Nippon Rubber Industry Public Company Limited
- Last refreshed: 19 September 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06595836.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing